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RESEARCH ARTICLE

Primary gamma-herpesviral infection in Zambian
children
Research article

Veenu Minhas1, Brad P Brayfield1, Kay L Crabtree1, Chipepo Kankasa2, Charles D Mitchell3 and Charles Wood*1

Abstract
Background: HHV-8 is closely related to Epstein-Barr virus (EBV), but the clinical presentations of these two infections
in early childhood are not well understood. Also, it is not known whether infection by one virus correlates with another.
Here, we compare the natural history of infection by these two viruses along with the clinical manifestations and risk
factors that are associated with early childhood infection in Zambia, which is an endemic area for HHV-8.
Methods: This study was conducted in a cohort of 12 month old Zambian children (N = 677). Data on socio-economic
status and a wide range of clinical manifestations were collected. Logistic regression was used to test for significant
associations between the collected variables and HHV-8 or EBV serostatus at 12 months of age.
Results: We observed a significantly higher seroprevalence for EBV (58.9%) as compared to HHV-8 (13.4%). HIV-1
infected children had at a significantly higher risk of being infected with HHV-8 (Odds ratio [OR] 3.69, 95% confidence
interval [CI] 1.64 - 8.32). HIV-1 infection of the mothers was a significant risk factor for increased acquisition of EBV but
not HHV-8 by children (OR 1.86, 05% CI 1.20 - 2.87). Self reported rash was marginally associated with primary infection
for HHV-8 and EBV.
Conclusions: These results suggest that there is no correlation between EBV and HHV-8 infections. Infection by one
does not increase the susceptibility for the second virus. Primary HHV-8 and EBV infection in early childhood may
clinically present as rash but remains largely asymptomatic and may remain undetected in this population. HIV
infection in the mother or child are important risk factors that contribute to EBV or HHV-8 infection.
Background
Human herpesvirus-8 (HHV-8), also known as Kaposi's
sarcoma-associated herpesvirus (KSHV) is a gamma-herpesvirus reported to be associated with all forms of
Kaposi's sarcoma (KS) [1,2]. HHV-8 is closely related to
Epstein-Barr virus (EBV), the only other known human
gamma-herpesvirus with both having a latent and lytic
phase of replication. EBV is the most commonly identified virus associated with AIDS-related non-Hodgkin
lymphomas, CNS lymphomas, African Burkitt's Lymphoma, and Nasopharyngeal Carcinoma [3,4]. HIV-associated immunosuppression has led to an increase in the
incidence of childhood Kaposi's sarcoma and non-Hodgkin lymphomas including African Burkitt's lymphoma in
sub-Saharan Africa [5].
* Correspondence: cwood@unlnotes.unl.edu
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Nebraska Center for Virology and School of Biological Sciences, University of
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Little is known about the acquisition of HHV-8 and
EBV in early childhood in endemic African countries like
Zambia especially after the onset of the HIV-1 epidemic
in this region. Whether infection by one virus enhances
the susceptibility to infection by the other in the context
of HIV-1 infection and immune-suppression is not
known. Most studies that documented the prevalence of
HHV-8 have sampled a cross-section of the population.
These studies have reported various factors that are associated with increased risk for HHV-8 prevalence but not
on primary HHV-8 infection and the associated clinical
symptoms. In addition, it is still not clear whether primary infection with HHV-8 produces an acute clinical
syndrome and what factors increase the risk of acquisition of HHV-8 and EBV. Only one study conducted on
immunocompetent children in Egypt has reported that
primary HHV-8 infection may present itself as a febrile
illness and the infected children developed a maculopapular rash [6]. Whether similar clinical symptoms are
observed in endemic areas such as Zambia and whether
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symptoms are similar for primary HHV-8 and EBV infections is still not known. As a part of our previous cohort
studies in Zambia, we recruited newborn infants and followed them for up to 48 months of age. We have found
that approximately 40% of children became infected with
HHV-8 by 48 months of age [7]. Our cohort provided us
an opportunity to further investigate early childhood
infection in children less than 12 months of age. We
anticipate that children of this age group will most likely
undergo primary infection rather than reactivation of
latent infection. Due to the prospective design and data
collection during follow-up, our study provides a unique
opportunity to examine potential risks with these two
herpesviruses in the same population.
The objective of this study was to determine HHV-8
and EBV seroprevalence in the children, the effect of
HIV-1 infection, the specific clinical manifestations and
the risk factors involved. Here, we report the prevalence
of HHV-8 and/or EBV serostatus in 12 month old Zambian children where primary infection event had
occurred. We also report the clinical symptoms during
the primary infection, the association of primary infection with the HIV-1 status of the child and analyze the
association of a positive serostatus at 12 months of age
with markers of social and economic status.

Methods
Study participants

Enrollment and follow-up- As described previously [7],
study participants were recruited as part of a prospective
cohort of mother/child pairs at the University Teaching
Hospital (UTH) in Lusaka, Zambia between October
1998 and April 2004. Women in the early stages of labor
and their newborn children were enrolled in a prospective cohort study after the mothers were counseled, educated about the study, and had given written informed
consent. The study was approved by the Institutional
Review Boards of the University of Zambia, University of
Nebraska, and University of Miami. A total of 1,424
mother-child pairs who returned for at least one postpartum visit constituted our longitudinal cohort (Figure
1).
Inclusion and exclusion criteria

Among the cohort of 684 children of 12 months of age,
adequate amount of plasma for reliable testing for HHV-8
and EBV was not available for 7 children. Therefore, the
present analysis includes 677 children who survived and
were followed up till at least 24 months of age in order to
establish reliable HIV-1 status. Children who did not
return for a follow-up visit at age 24 months (n = 740)
were excluded from this analysis. Other reasons for
exclusion included early mortality, early withdrawal, and
loss to follow-up before HIV-1 serostatus could be reliably established. Diagnostic PCR testing for HIV-1 in
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children below 18 months of age was not available in
Zambia at the time of this study. Therefore, HIV-1 serology was performed between 18 - 24 months of age. By 24
months of age, 6 percent (41/677) of the children tested
positive for HIV-1.
Serological testing

Blood specimens collected from children were coded by a
unique identification number and analyzed without
knowledge of the personal identity of the study participants. To rule out detection of transplacental maternal
HHV-8 antibodies, child plasma was not screened for
HHV-8 infection until the age of 12 months and for HIV1 infection until the age of 18 months.
HHV-8 serology

All plasma samples were tested by monoclonal-enhanced
immunofluorescence assay (mIFAs) as described previously [8]. Briefly, BC3 mIFAs were conducted by stimulating BC-3 cells with tetradecanoyl phorbol acetate
(TPA), which were then fixed with 4% paraformaldehyde
and permeabilized after 72 hours. To reduce subjectivity
in observing specific fluorescence, slides were read independently by two laboratory workers. All plasma determined to be positive by BC-3 mIFA was further
confirmed using Sf9 mIFA. Recombinant baculoviruses
expressing glutathione S-transferase tagged lytic proteins, ORF65 and K8.1A, and latent protein, ORF73 were
used to develop Sf9 mIFAs. Baculovirus-infected Sf9 cells
expressing GST alone were used as a negative control to
detect background and nonspecific fluorescence. All
infections were initiated separately, to maximize the level
of proteins produced, harvested at 72 hpi and fixed using
the BC3 cell method. The procedure of Sf9 mIFA was the
same as that for BC3 mIFA. A sample was considered
seropositive for HHV-8 only if it was positive at a standard serum dilution of 1:40 for both BC3 and Sf9 mIFA
(with at least one antigen). To rule out the detection of
residual maternal antibodies, plasma of all HHV-8-seropositive children at 12 months who were born to HHV-8seropositive mothers was titered at birth, at 6 months,
and at 12 months. Primary infection event occurred
when previously seronegative children became seropositive at 12 months of age.
EBV serology

IgG antibodies against EBV viral capsid antigen (VCA)
were detected using a standard Enzyme Linked Immunosorbent Assay kit. (ELISA) (Diagnostic Automation, California). This commercially available kit is based on
recombinant purified protein of the VCA complex and
has a specificity and sensitivity of 100% as reported by the
manufacturer. Plasma was diluted 1:21 as per the manufacturer's instructions, and three calibrators and control
sera were tested in each test run. The optical density was
read on a microplate reader (Biotek instruments) at 450
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Figure 1 Flowchart of study cohort. Flowchart summarizing the longitudinal cohort followed to study herpesviral infection in children in Lusaka,
Zambia, 1998-2004. The present analysis includes 677 children who survived/returned at 12 months of age in order to establish reliable HHV-8, EBV
and HIV-1 diagnosis.

nm. Results were accepted when all the quality control
criteria were met as per the manufacturer's recommendation.
HIV-1 Test

All plasma was screened by a standard HIV-1 test kit
(Capillus HIV-1/2 Agglutination test kit, Trinity Biotech.)
and confirmed for HIV-1 antibodies by another standard
kit (Abbott Determine HIV-1/2 EIA, Abbott Laboratories).
Statistical Analysis

Data was analyzed using the statistical software package,
SPSS version 17 (SPSS, Chicago, IL). Logistic regression
was used to test for significant associations between the
collected variables and serostatus at 12 months of age.
Univariate test of association was performed, and odds
ratio and 95% confidence intervals (CI) were calculated.
We also tested for interactions and multicollinearity by
checking the correlation between various variables. Multivariate analysis included all variables that had a p-value
≤ 0.05 to control for possible confounders and identify
independent associations.

Results
Study participants and prevalence of infection: For this
report, evidence of seroconversion for HHV-8 and EBV
was determined for 677 children when they reached 12
months of age. However, of these 677 children, 655 children were also followed up at least once or more at 2, 4 or
6 months of age also. The remaining 22 children were followed up directly at 12 months of age after enrollment at
birth. While analyzing factors associated with seroconversion; 'ever' denotes that the child experienced that
condition at least once or more during the 12 month follow-up period and 'never' denotes that the child was
never reported to experience that condition during any
follow-up visit. Follow-up information was collected
when the patient visited the clinic or by active follow-up
at the place of residence. At each follow-up visit, trained
nurses administered a structured questionnaire in order
to obtain information about the socio-economic status,
demographic data and medical history of the recruited
patients. The questionnaire data collected and analyzed
for this report is based on all prominent published studies
on HHV-8 prevalence and incidence. Data on sociodemographic factors, ailments, illnesses or symptoms
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experienced, and information on any medications or
treatments received since the last visit were recorded
during these visits.
In the cohort of 12 month old Zambian children (N =
677), the prevalence of HHV-8+ EBV- children was
4.14%. We also observed that in this cohort the seroprevalence of EBV to be significantly higher than HHV-8. The
prevalence of HHV-8- EBV+ children was 49.63% demonstrating that in this population a significantly larger
number of children were infected with EBV alone as compared to HHV-8 alone (Figure 2). Prevalence of dually
infected (HHV-8+ EBV+) children was 9.30%.
Primary HHV-8 infection and associated clinical manifestations: Associations between primary HHV-8 infection and a range of socio-demographic characteristics
and medical characteristics indicative of the general
health of the child were evaluated (Table 1). In a univariate analysis, a self-reported history of rashes was significantly associated with primary HHV-8 infection (OR
1.84, 95% CI - 1.13-3.01). Also, children who were HIV-1
seropositive at 12 months of age (OR 4.79, 95% CI - 2.449.38), were infected with EBV or were born to HIV-1
infected mothers had increased odds of primary HHV-8
infection as compared to those who were not. Multivariate analysis indicated that HIV-1 seropositive status (at
18 months of age) was independently associated with pri-
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mary HHV-8 infection (OR 3.69, 95% CI - 1.64-8.32).
After adjusting for confounders, we also observed a weak
association between history of rashes in children with
primary HHV-8 infection (OR 1.54, 95% CI- 0.92-2.56)
but no association with EBV infection. No other selfreported clinical symptoms or socio-demographic characteristics were significantly associated with primary
HHV-8 infection. These included self reported history of
all common medical conditions (fever, diarrhea, cough,
malaria, conjunctivitis, oral thrush) and indirect measures of the health of the child (use of antibiotics, hematinics, multivitamins and administration of traditional
therapy).
Primary EBV infection and associated clinical manifestations: We also compared the prevalence of primary
EBV infection and associated clinical characteristics in
the same cohort of 12 month old Zambian children
(Table 2). We observed that in a univariate analysis, self
reported rash was also associated with EBV infection in
children at 12 months (OR 1.56, 95% CI 1.06-2.3). Also,
other factors such as fever in the child, low education of
mother and HIV infection in the child or mother were
individually associated with EBV infection at 12 months.
Upon multivariate analysis, we observed that low education of the mother and HIV infection in mother were
individually associated with EBV infection (OR 1.51, 95%

Figure 2 Prevalence of HHV-8 and EBV infection. Bar graph depicting the prevalence of HHV-8 and EBV positive children in 12 month old children
(N = 677) in Lusaka, Zambia, 1998-2004.
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Table 1: Risk factors associated with primary HHV-8 infection.
Unadjusted Analysis
Positive/Total No.a

p-value

OR (95% CI)

0.20

0.75 (0.48 - 1.17)

Adjusted Analysisb
p-value

OR (95% CI)

0.66

1.14 (0.63 - 2.08)

Socio-Demographic Characteristics

Gender
- Male

41/347

- Female

50/330

Reference

Ethnic Group
- Nyanja

45/308

0.17

1.47 (0.85 - 2.56)

- All others

25/167

0.19

1.52 (0.82 - 2.82)

- Bemba

21/202

Reference

Mothers Education
- 0-7 years

45/348

- 8 or more years

46/329

0.69

0.91 (0.59 - 1.42)
Reference

Mothers Employment
- Unemployed

78/566

- Employed

13/109

0.60

0.85 (0.45 - 1.59)
Reference

Monthly Income
- less than 100,000 ZMK

42/309

- more than 100,000 ZMK

49/368

0.92

0.66 - 1.59)
Reference

Household members
- 6 or more

32/247

- 2 to 5

57/418

0.80

0.94 (0.59 - 1.50)
Reference

HIV infection (mother)
- Positive

30/149

- Negative

61/528

0.01

1.93 (1.19 - 3.12)
Reference

Child Characteristicsc

Birth weight of child
- less than 3.2 Kg

53/430

- more than 3.2 Kg

38/244

0.24

0.76 (0.49 - 1.20)
Reference

Diarrhea
- Ever

36/238

- Never

54/436

0.32

1.26 (0.80 - 1.99)
Reference

Fever
- Ever

38/270

- Never

52/404

0.65

1.11 (0.71 - 1.74)
Reference

Cough
- Ever

52/371

- Never

38/303

0.58

1.14 (0.73 - 1.78)
Reference

Reference
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Table 1: Risk factors associated with primary HHV-8 infection. (Continued)
Rashes
- Ever

28/143

- Never

62/531

0.01

1.84 (1.13 - 3.01)

0.10

Reference

1.54 (0.92 - 2.56)
Reference

Malaria
- Ever

11/78

- Never

79/596

0.84

1.07 (0.54 - 2.12)
Reference

HIV infection (child)
- Positive

16/41

- Negative

75/636

<0.001

4.79 (2.44 - 9.38)

0.002

Reference

3.69 (1.64 - 8.32)
Reference

EBV infection
- Positive

63/399

- Negative

28/278

0.03

1.67 (1.04 - 2.69)
Reference

0.14

1.45 (0.89 - 2.36)
Reference

Antibiotics
- Ever

68/475

- Never

22/199

0.26

1.34 (0.81 - 2.24)
Reference

Traditional therapy
- Yes

12/61

- No

78/613

0.13

1.68 (0.86 - 3.30)
Reference

Multivitamin use
- Ever
- Never

7/32

0.15

83/642

1.89 (0.79 - 4.50)
Reference

OR- Odds Ratio, CI- Confidence Interval, ZMK- Zambian Kwacha.
aTotal number may not add up to 677 in all categories due to missing values.
bAdjusted analysis includes all variables with p-value ≤ 0.05 in the unadjusted analysis.
cData on lymphadenopathy, pneumonia, conjunctivitis, oral thrush and hematinics use in the child were also analyzed but not shown in this
table.
Unadjusted and adjusted odds ratios to predict association between primary HHV-8 infection in a cohort of 677 children and sociodemographic characteristics and medical conditions in Lusaka, Zambia, 1998-2004.

CI 1.11-2.06 and OR 1.86, 95% CI 1.20-2.87, respectively).
As observed with HHV-8, no other self-reported clinical
symptoms (rashes, fever, diarrhea, cough, malaria, conjunctivitis, and oral thrush), indirect measures of the
health of the child (use of antibiotics, hematinics, multivitamins and administration of traditional therapy) and
socio-demographic characteristics were significantly
associated with primary HHV-8 infection.

Discussion
Very little is known about the clinical manifestations
associated with primary infection with HHV-8 in early
childhood and factors that may be associated with primary infection or an increase in risk of infection, especially in HIV-1 infected children, in an endemic region
such as Zambia. The majority of the seroprevalence studies are cross-sectional in design, making it difficult to
detect primary infection. Both HHV-8 and EBV are oncogenic gamma-herpesviruses that have a similar mode of
transmission, most likely through saliva [9,10]. Therefore,

the major aim of this study was to investigate primary
HHV-8 and EBV infection, compare the clinical manifestations associated with primary infection and whether
they have a similar mode of transmission and whether
there is an association between HHV-8 and EBV infection. Detailed analysis of these could provide important
information regarding the patterns of transmission, natural history of infection and the susceptible population at
higher risk for infection.
Our study has several strengths. We were able to analyze a well characterized cohort of children and their
caregivers. We also collected a wide range of data in the
form of questionnaires that were administered at each
follow-up visit. These questionnaires collected information on most common symptoms and illnesses and any
information that may indirectly depict a poor health status of the child. This study was conducted on children
from an established cohort of mother-child pairs
recruited at the University Teaching Hospital, the affiliated teaching hospital for the University of Zambia
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Table 2: Risk factors associated with primary EBV infection.
Unadjusted Analysis

Positive/Total No.a

p-value

OR (95% CI)

0.39

0.87 (0.64 - 1.19)

Adjusted Analysisb

p-value

OR (95% CI)

0.006

1.56 (1.14 - 2.13)

Socio-Demographic Characteristics

Gender
- Male

199/347

- Female

200/330

Reference

Ethnic Group
- Nyanja

182/308

0.88

1.03 (0.72 - 1.47)

- All others

99/167

0.87

1.04 (0.68 - 1.57)

- Bemba

118/202

Reference

Mothers
Education
- 0-7 years

222/348

- 8 or more
years

177/329

0.01

1.51 (1.11 - 2.06)
Reference

Reference

Mothers
Employment
Unemployed

331/566

- Employed

61/109

0.56

1.13 (0.74 - 1.72)
Reference

Monthly Income
- less than
100,000 ZMK

189/309

- more than
100,000 ZMK

210/368

0.28

1.18 (0.87 - 1.61)
Reference

Household
members
- 6 or more

148/247

- 2 to 5

245/418

0.74

1.06 (0.77 - 1.45)
Reference

HIV infection
(mother)
- Positive

108/149

- Negative

291/528

<0.001

2.15 (1.44 - 3.2)
Reference

Child Characteristicsc

Birth weight of
child
- less than 3.2
Kg

251/430

- more than
3.2 Kg

147/244

0.72

0.95 (0.69 - 1.29)
Reference

Diarrhea
- Ever

140/238

0.98

0.99 (0.72 - 1.37)

0.005

1.86 (1.20 - 2.87)
Reference
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Table 2: Risk factors associated with primary EBV infection. (Continued)
- Never

257/436

Reference

Fever
- Ever

168/270

- Never

229/404

0.15

1.26 (0.92 - 1.72)
Reference

Cough
- Ever

214/371

- Never

183/303

0.48

0.89 (0.66 - 1.22)
Reference

Rashes
- Ever

96/143

- Never

301/531

0.02

1.56 (1.06 - 2.3)

0.08

Reference

1.43 (0.96 - 2.13)
Reference

Malaria
- Ever
- Never

48/78

0.61

349/596

1.13 (0.7 - 1.84)
Reference

HIV infection
(child)
- Positive

63/91

- Negative

336/586

0.03

1.67 (1.04 - 2.69)

0.14

Reference

1.44 (0.88 - 2.36)
Reference

EBV infection
- Positive

33/41

- Negative

41/636

0.01

3.04 (1.38 - 6.69)

0.27

1.64 (0.67 - 3.90)

Reference

Antibiotics
- Ever

273/475

0.24

- Never

124/199

Reference

- Yes

40/61

0.27

- No

357/613

0.82 (0.58 - 1.15)

Traditional
therapy
1.37 (0.79 - 2.37)
Reference

Multivitamin use
- Ever
- Never

20/32

0.67

377/642

1.17 (0.56 - 2.44)
Reference

OR- Odds Ratio, CI- Confidence Interval, ZMK- Zambian Kwacha.
aTotal number may not add up to 677 in all categories due to missing values.
bAdjusted analysis includes all variables with p-value ≤ 0.05 in the unadjusted analysis.
cData on lymphadenopathy, pneumonia, conjunctivitis, oral thrush and hematinics use in the child were also analyzed but not shown in this
table.
Unadjusted and adjusted odds ratios to predict association between primary EBV infection in a cohort of 677 children and socio-demographic
characteristics and medical conditions in Lusaka, Zambia, 1998-2004.

School of Medicine in Lusaka, Zambia to study the epidemiology and transmission of HHV-8 in a population that
is an endemic area for HHV-8 infection. Our results
clearly show that children are infected by both HHV-8
and EBV very early in life. HHV-8 and EBV have been
reported to have similar modes of transmission, via
saliva. Interestingly, our results show that the incidence of
EBV early in childhood is significantly higher as compared to HHV-8. A very similar seroprevalence rate has
been reported for EBV in some Asian countries such as
India, where Venkitaraman et al have reported that IgG

antibodies to VCA rose rapidly to 90% by 5 years of age
[11]. The prevalence of VCA-specific IgM and the geometric mean titer of VCA-specific IgG antibodies were
highest between the ages of 6 months and 2 years, the
median age of primary infection being 1.4 years. Primary
infection in Malaysian children reportedly occurs at 4-6
months. Thus the transmission for EBV is either more
effective or occurring at a much higher rate as compared
to HHV-8, possibly as a result of more frequent exposure.
Indeed, a recent study from Uganda has reported that the
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detection of EBV DNA in saliva was more frequent than
HHV-8 DNA [12].
Both EBV and HHV-8 have been reported to have similar modes of transmission via salivary contact, low socioeconomic status and overcrowded living conditions have
been considered as a risk factor for acquiring both HHV8 and EBV. A study conducted on Ugandan children
found a direct association of HHV-8 infection with low
socio-economic status and the use of surface water [13].
In our study socio-demographic information was collected at birth and data on recent medical history provided by the caregiver, which may directly or indirectly
help in assessing the health of the child, were collected at
each follow-up visits. We did not observe any association
of primary infection with HHV-8 with the reported
socio-economic characteristics, including monthly
income, mother's educational level, household size or
ethnicity. However, direct comparison of different HHV8 serological studies can be difficult sometimes because
of different serological tests that are used for diagnosis of
HHV-8 infection, the difference in the age of the children
and study cohort. As expected, we did observe that primary infection with EBV was significantly increased in
children whose mothers had 7 years or less of education.
However, assessing socio-economic status is complex and
our questionnaire was not designed to examine direct
markers of socio-economic status, therefore the collected
information can only provide indirect information about
the socio-economic status of the household.
We also analyzed a range of child characteristics that
may be associated with HHV-8 and EBV infection in children, and found that HIV-1 infection was found to be a
major risk factor. Our earlier studies have found that
HIV-1 infected children were more likely to be infected
with HHV-8 [7]. Interestingly, unlike HHV-8 we did not
find HIV-1 infection risk to be risk factor for EBV infection and we did not find a correlation between EBV and
HHV-8 infection in this group of children. These results
also show that in the case of EBV the immune status of
the child may not be an important factor and that most
children in this cohort, regardless of their HIV-1 status,
will get infected early in life. In fact, by 2 years of age, we
observed that the seroprevalence for EBV was 92% in the
same cohort (data not shown). It is possible that for
HHV-8, the immune status of the child plays a more significant role while in case of EBV it is the status of the
transmitters that is more important. Multivariate analysis
showed that HIV-1 infection in mothers was associated
with higher risk of EBV infection in children as compared
to children born to HIV-1 uninfected mothers. This is
most likely because the HIV-1 positive mothers are more
likely to have higher EBV viral loads and thus shed more
virus in their saliva as compared to HIV-1 negative mothers [14]. Another study, conducted in Canada, has
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reported similar results where children born to HIV-1
infected mothers seroconverted earlier for EBV, than
children born to HIV-1 uninfected mothers [15]. Lack of
availability of HAART at the time of this study may have
resulted in a high level of transmission of HIV-1 to children but its impact on HHV-8 and EBV transmission is
hard to estimate. It is clear that these viruses interact with
HIV that predisposes HIV-infected individuals to malignancies. In general, while the risk of developing nonHodgkins lymphomas in AIDS patients in Africa is lower
as compared to United States, it is thought to be associated with severe immunosuppression, poor prognosis
and shorter mean survival of the African patients [16-18].
Our data suggests that children who were reported to
have had rashes were more likely to seroconvert for
HHV-8. Presence of rashes was marginally associated
with infections with both HHV-8 and EBV. In fact, primary HHV-8 infection has been reported to be associated with the presence of maculopapular rash [6]. In our
study the association was not as strong but it could have
been due to difference in population sampling. In the
study reported by Andreoni et al children admitted to the
emergency ward were sampled which could have biased
the study towards observing more severe cases [6]. In our
study the follow-up questionnaire did not distinguish
between various kinds of rashes; therefore, it is difficult
for us to determine an association with a specific type of
rash. Overall, appearance of rashes may be indicative of
primary infection with either one or both of these infections and a larger sample size would be necessary to
examine this association further. Malaria is also endemic
in Zambia and we did not find any association between
seroconversion for either EBV or HHV-8 with a recent
history of malaria. While malaria may not be a risk factor
for seroconversion to either virus, a recent study has suggested that EBV and malaria may act synergistically in the
pathogenesis of childhood Burkitt lymphoma [19], most
likely through the direct reactivation of the virus [20,21].
Our study has several limitations. Firstly, reporting or
recall bias leading to exposure misclassification could not
be entirely ruled out. In a majority of the cases, the children came back with the caregivers multiple times during
the 12 month period. This allowed us to document clinical symptoms at regular intervals. But 22 children came
directly at 12 months after their enrollment at birth. This
could have led to an underreporting of clinical symptoms
from which a child may have suffered. Secondly, it has
been reported by Mbulaiteye et al that households with
limited access to water may increase the risk for HHV-8
infection [13]. Whether it increases the risk for HHV-8 or
EBV primary infection in early childhood could not be
analyzed in the present study because this data was not
collected. Third, we cannot exactly pinpoint as to when
the primary infection event for HHV-8 or EBV took place
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during the 12 month period. Therefore, it is difficult to
argue that associated symptoms could be attributed
entirely to either EBV or HHV-8 seroconversion. The
number of children who were seropositive for HHV-8 or
EBV alone was small to draw decisive conclusions. Lastly,
we cannot rule out that the associated symptoms were
entirely due to primary seroconversion and not due to
reactivation of HHV-8. However, based on our previous
study it is likely that children under 12 months of age are
usually undergoing primary HHV-8 infection.
While a large percentage of children will eventually
become infected by EBV and as we have reported earlier
that there is a steady increase in HHV-8 infection in early
childhood with age in Zambia, the impact of these infections on the population in the context of HIV-1 infection
is not clear. It is possible that the infection by one or both
of the viruses may increase the susceptibility to HIV-1
infection or vice versa, as we have observed a significant
co-relation between HIV-1 and the two viruses. It is possible that dual infection may affect the disease progression because it has been reported that HHV-8 and EBV
may interact at the molecular level and may promote the
establishment of latency [22]. Therefore, a better understanding of the interaction between these viruses may
lead to the development of better strategies to manage
these infections and also in prevention of infection in
early childhood.

Conclusions
Taken together these results suggest that there is no correlation between primary HHV-8 and EBV infection. Primary infection with HHV-8 may clinically present as rash
but remains largely asymptomatic in early childhood in
Zambia. Because of mild and non-descript symptoms
associated with primary infection of HHV-8, it may
remain undetected or untreated in this population. Our
results also suggest that HIV-1 infection of the mother
may be associated with increased risk of EBV infection
for the child. HIV-1 infected children are significantly
more likely to acquire HHV-8 infection as compared to
HIV-1 uninfected children.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
VM contributed to conceptual design, data cleaning, interpretation, and preparation of the final manuscript. BPB contributed to conceptual design, and preparation of the manuscript. KLC participated in the implementation of the study.
CK participated in study design and data collection. CDM contributed to study
design and drafting of the manuscript. CW contributed to overall scientific
management, interpretation of data and writing of manuscript. All authors
read and approved the final manuscript.
Acknowledgements
We would like to thank the study subjects for their participation in this study.
We thank the staff at the clinic and the laboratory at UTH, Zambia and Mr
Chafye Siuluta for help in recruitment of patients, sample processing and coor-

Page 10 of 11

dinating the field work. This work was supported by National Institutes of
Health (PHS grants RO1 CA75903, T32 AI060547 to C.W.), Fogarty International
Training grant (D43 TW01492 to C.W.) and National Center for Research
Resources Centers of Biomedical Research Excellence grant (P20 RR15635 to
CW). KLC is supported by Ruth L. Kirschstein National Research Service Award
from the National Institute of Allergy and Infectious Diseases and by the INBRE
program P20 RR016469 of the National Center for Research Resources. The
funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Author Details
1Nebraska Center for Virology and School of Biological Sciences, University of
Nebraska-Lincoln, Lincoln, NE 68583 USA, 2Department of Paediatrics and
Child Health, University Teaching Hospital, Lusaka, Zambia and 3Department
of Pediatrics, University of Miami School of Medicine, Miami, FL, 33133 USA
Received: 11 January 2010 Accepted: 12 May 2010
Published: 12 May 2010
©
This
BMC
2010
is
article
Infectious
an
Minhas
Open
is available
Diseases
et
Access
al; licensee
from:
article
2010,http://www.biomedcentral.com/1471-2334/10/115
BioMed
10:115
distributed
Central
under
Ltd.
the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References
1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore
PS: Identification of herpesvirus-like DNA sequences in AIDSassociated Kaposi's sarcoma. Science 1994, 266:1865-1869.
2. Huang YQ, Li JJ, Kaplan MH, Poiesz B, Katabira E, Zhang WC, Feiner D,
Friedman-Kien AE: Human herpesvirus-like nucleic acid in various forms
of Kaposi's sarcoma. Lancet 1995, 345:759-761.
3. Carter KL, Cahir-McFarland E, Kieff E: Epstein-barr virus-induced changes
in B-lymphocyte gene expression. J Virol 2002, 76:10427-10436.
4. Young LS, Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer
2004, 4:757-768.
5. Chintu C, Athale UH, Patil PS: Childhood cancers in Zambia before and
after the HIV epidemic. Arch Dis Child 1995, 73:100-104.
6. Andreoni M, Sarmati L, Nicastri E, El Sawaf G, El Zalabani M, Uccella I,
Bugarini R, Parisi SG, Rezza G: Primary human herpesvirus 8 infection in
immunocompetent children. JAMA 2002, 287:1295-1300.
7. Minhas V, Crabtree KL, Chao A, M'Soka TJ, Kankasa C, Bulterys M, Mitchell
CD, Wood C: Early childhood infection by human herpesvirus 8 in
Zambia and the role of human immunodeficiency virus type 1
coinfection in a highly endemic area. Am J Epidemiol 2008, 168:311-320.
8. Minhas V, Crosby LN, Crabtree KL, Phiri S, M'Soka TJ, Kankasa C, Harrington
WJ, Mitchell CD, Wood C: Development of an immunofluorescence
assay using recombinant proteins expressed in insect cells to screen
and confirm presence of human herpesvirus 8-specific antibodies. Clin
Vaccine Immunol 2008, 15:1259-1264.
9. Brayfield BP, Kankasa C, West JT, Muyanga J, Bhat G, Klaskala W, Mitchell
CD, Wood C: Distribution of Kaposi sarcoma-associated herpesvirus/
human herpesvirus 8 in maternal saliva and breast milk in Zambia:
implications for transmission. J Infect Dis 2004, 189:2260-2270.
10. Young LS: Epstein-Barr-virus infection and persistence: a B-cell
marriage in sickness and in health. Lancet 1999, 354:1141-1142.
11. Venkitaraman AR, Lenoir GM, John TJ: The seroepidemiology of infection
due to Epstein-Barr virus in southern India. J Med Virol 1985, 15:11-16.
12. Mbulaiteye SM, Walters M, Engels EA, Bakaki PM, Ndugwa CM, Owor AM,
Goedert JJ, Whitby D, Biggar RJ: High levels of Epstein-Barr virus DNA in
saliva and peripheral blood from Ugandan mother-child pairs. J Infect
Dis 2006, 193:422-426.
13. Mbulaiteye SM, Biggar RJ, Pfeiffer RM, Bakaki PM, Gamache C, Owor AM,
Katongole-Mbidde E, Ndugwa CM, Goedert JJ, Whitby D, Engels EA:
Water, socioeconomic factors, and human herpesvirus 8 infection in
Ugandan children and their mothers. J Acquir Immune Defic Syndr 2005,
38:474-479.
14. Miller CS, Berger JR, Mootoor Y, Avdiushko SA, Zhu H, Kryscio RJ: High
prevalence of multiple human herpesviruses in saliva from human
immunodeficiency virus-infected persons in the era of highly active
antiretroviral therapy. J Clin Microbiol 2006, 44:2409-2415.
15. Pedneault L, Lapointe N, Alfieri C, Ghadirian P, Carpentier L, Samson J,
Joncas J: Natural history of Epstein-Barr virus infection in a prospective
pediatric cohort born to human immunodeficiency virus-infected
mothers. J Infect Dis 1998, 177:1087-1090.

Minhas et al. BMC Infectious Diseases 2010, 10:115
http://www.biomedcentral.com/1471-2334/10/115

16. Lucas SB, De Cock KM, Peacock C, Diomande M, Kadio A: Effect of HIV
infection on the incidence of lymphoma in Africa. East Afr Med J 1996,
73:S29-30.
17. Patil P, Elem B, Zumla A: Pattern of adult malignancies in Zambia (19801989) in light of the human immunodeficiency virus type 1 epidemic.
J Trop Med Hyg 1995, 98:281-284.
18. Thomas JO: Acquired immunodeficiency syndrome-associated cancers
in Sub-Saharan Africa. Semin Oncol 2001, 28:198-206.
19. Carpenter LM, Newton R, Casabonne D, Ziegler J, Mbulaiteye S, Mbidde E,
Wabinga H, Jaffe H, Beral V: Antibodies against malaria and Epstein-Barr
virus in childhood Burkitt lymphoma: a case-control study in Uganda.
Int J Cancer 2008, 122:1319-1323.
20. Chene A, Donati D, Guerreiro-Cacais AO, Levitsky V, Chen Q, Falk KI, Orem
J, Kironde F, Wahlgren M, Bejarano MT: A molecular link between malaria
and Epstein-Barr virus reactivation. PLoS Pathog 2007, 3:e80.
21. Donati D, Espmark E, Kironde F, Mbidde EK, Kamya M, Lundkvist A,
Wahlgren M, Bejarano MT, Falk KI: Clearance of circulating Epstein-Barr
virus DNA in children with acute malaria after antimalaria treatment. J
Infect Dis 2006, 193:971-977.
22. Xu D, Coleman T, Zhang J, Fagot A, Kotalik C, Zhao L, Trivedi P, Jones C,
Zhang L: Epstein-Barr virus inhibits Kaposi's sarcoma-associated
herpesvirus lytic replication in primary effusion lymphomas. J Virol
2007, 81:6068-6078.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/10/115/prepub
doi: 10.1186/1471-2334-10-115
Cite this article as: Minhas et al., Primary gamma-herpesviral infection in
Zambian children BMC Infectious Diseases 2010, 10:115

Page 11 of 11

